𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mycophenolate mofetil for interstitial lung disease in dermatomyositis

✍ Scribed by Pamela A. Morganroth; Mary Elizabeth Kreider; Victoria P. Werth

Publisher
Wiley (John Wiley & Sons)
Year
2010
Tongue
English
Weight
136 KB
Volume
62
Category
Article
ISSN
2151-464X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pneumomediastinum in interstitial lung d
Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis
✍ Le Goff, Benoit ;ChΓ©rin, Patrick ;Cantagrel, Alain ;Gayraud, Martine ;Hachulla, πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 111 KB πŸ‘ 1 views

## Abstract ## Objective Spontaneous pneumomediastinum is a rare complication of dermatomyositis (DM) and polymyositis (PM). The aim of this study was to characterize this complication and determine its prognostic factors. ## Methods We retrospectively collected a multicenter series of PM/DM cas

Mycophenolic acid area under the curve c
Mycophenolic acid area under the curve correlates with disease activity in lupus patients treated with mycophenolate mofetil
✍ NoΓ«l Zahr; Laurent Arnaud; Pierre Marquet; Julien Haroche; Nathalie Costedoat-Ch πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 151 KB

Objective. Mycophenolic acid (MPA) is the active metabolite of mycophenolate mofetil (MMF), which is widely used to treat systemic lupus erythematosus (SLE). In transplantation, MPA area under the plasma concentration-time curve from 0 to 12 hours (MPA AUC 0-12 ) is correlated with clinical outcome.